| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 4 securities · passive | ||||||
|
Xperi Inc.
13G/A
XPER · 98423J101
|
5.1% |
8/14/2026
Event 6/30/2026
|
||||
| Clearline Capital LP | 5.1% | |||||
| Clearline Capital LLC | 5.1% | |||||
| Marc Majzner | 5.1% | |||||
|
MAGNACHIP SEMICONDUCTOR Corp
13G/A
MX · 55933J203
|
4.1% |
2/17/2026
Event 12/31/2025
|
||||
| Clearline Capital LP | 4.1% | |||||
| Clearline Capital, LLC | 4.1% | |||||
| Marc Majzner | 4.1% | |||||
|
Heron Therapeutics, Inc. /DE/
13G/A
HRTX · 427746102
|
6.7% |
2/17/2026
Event 12/31/2025
|
||||
| Clearline Capital LP | 6.7% | |||||
| Clearline Capital LLC | 6.7% | |||||
| Marc Majzner | 6.7% | |||||
|
TherapeuticsMD, Inc.
13G
TXMD · 88338N206
|
5.5% |
2/12/2025
Event 12/31/2024
|
||||
| Clearline Capital LP | 5.5% | |||||
| Clearline Capital, LLC | 5.5% | |||||
| Marc Majzner | 5.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.